A large team of medical researchers at the University of California, San Francisco, and CellSight Technologies has found that some patients who develop long COVID show signs of uncharacteristic immune cell activity in many ...
As Americans brace themselves for another summer of brutal heat and humidity, the American Heart Association (AHA) warns that heart patients need to take extra precautions to protect themselves.
Jul 6, 2024
0
2
A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Jul 6, 2024
0
139
Acupuncture is associated with improved sleep quality in patients with Parkinson disease, according to a study published online June 26 in JAMA Network Open.
Jul 5, 2024
0
5
Researchers from Sinai Health and the University of Toronto have gleaned new insights into how thyroid cancer could be more effectively treated.
Jul 5, 2024
0
30
Every two days, Lynn Oxenberg leans over her bathroom sink while her husband shaves the shadow of auburn hair beginning to cover her head.
Jul 5, 2024
0
0
The road leading to a career in pediatrics is becoming more deserted these days, and the decline in subspecialty interest has led to significant concerns regarding the ability of health care professionals to meet the growing ...
Jul 4, 2024
0
31
A new Finnish study from the University of Turku shows that a 30-minute exercise session can increase the proportion of tumor-killing white blood cells in the bloodstream of breast cancer patients.
Jul 3, 2024
0
3
For patients undergoing urinary diversion for neurogenic bladder (NGB), the postoperative impact on urinary-related quality of life (UrQOL) is milder for spinal cord injury of congenital (C-SCI) etiology versus acquired (A-SCI) ...
Jul 3, 2024
0
0
The European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the French pharmaceutical giant said on Wednesday.
Jul 3, 2024
0
0
